Literature DB >> 8244274

Role of ethanol-inducible cytochrome P-450 2E1 in the development of hepatocellular carcinoma by the chemical carcinogen, N-nitrosodimethylamine.

M Tsutsumi1, Y Matsuda, A Takada.   

Abstract

Cytochrome P-450 2E1 is a specific isozyme of cytochrome P-450 induced by ethanol. P-450 2E1 may also be the only enzyme that metabolizes N-nitrosodimethylamine at a very low concentration. Because N-nitrosodimethylamine is a procarcinogen, the possibility that induction of P-450 2E1 by alcohol abuse may accelerate the carcinogenic action of a very small dose of N-nitrosodimethylamine should be considered. To investigate this possibility, effects of ethanol on the hepatic carcinogenic action of a very small dose of N-nitrosodimethylamine were analyzed in rats. Sixty Wistar male rats were divided into two groups (ethanol and control) according to the liquid diets they were fed. After preliminary feeding, N-nitrosodimethylamine in two concentrations (1.5 ng/ml and 3.0 micrograms/ml) in drinking water was given with the diets for 40 or 60 wk. To avoid metabolic competition between ethanol and n-nitrosodimethylamine, we gave N-nitrosodimethylamine and the diets alternately. The average amount of N-nitrosodimethylamine consumed per day was 11 to 37 ng/kg body weight in the 1.5-ng group and was 27 to 37 micrograms/kg body weight in the 3.0-microgram group. Hepatic P-450 2E1 content was six times higher in the ethanol-treated groups than in the control groups throughout the experiment. Visible nodules and enzyme-altered foci were not found in rats in any group at the end of the fortieth week. These preneoplastic changes were found at the end of the sixtieth week only in rats in the groups treated with both ethanol and N-nitrosodimethylamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244274

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Sex steroid hormones regulate constitutive expression of Cyp2e1 in female mouse liver.

Authors:  Maria Konstandi; Jie Cheng; Frank J Gonzalez
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-02       Impact factor: 4.310

3.  RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Authors:  J M Ladero; J A Agúndez; A Rodríguez-Lescure; M Diaz-Rubio; J Benítez
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

Review 4.  Cocarcinogenic effects of alcohol in hepatocarcinogenesis.

Authors:  F Stickel; D Schuppan; E G Hahn; H K Seitz
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

5.  Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.

Authors:  Ayman S Bannaga; Heena Tyagi; Emma Daulton; James A Covington; Ramesh P Arasaradnam
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

6.  Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro.

Authors:  De-Fu Hou; Shui-Liang Wang; Zhi-Min He; Fang Yang; Zhu-Chu Chen
Journal:  Mol Cell Biochem       Date:  2006-12-05       Impact factor: 3.842

7.  Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axis.

Authors:  Hiroyuki Kato; Aya Naiki-Ito; Taku Naiki; Shugo Suzuki; Yoriko Yamashita; Shinya Sato; Hiroyuki Sagawa; Akihisa Kato; Toshiya Kuno; Satoru Takahashi
Journal:  Oncotarget       Date:  2016-01-12

8.  Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.

Authors:  Yufeng Sun; Wenchao Li; Shiqi Shen; Xuejing Yang; Bing Lu; Xiaojing Zhang; Peng Lu; Yi Shen; Juling Ji
Journal:  J Transl Med       Date:  2019-11-26       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.